In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment-Reference-Cited by-同舟云学术

In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment

Published:2019-06-26 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Rodriguez Dunia,Goulart Cibelly,Pagliarone Ana C.,Silva Eliane P.,Cunegundes Priscila S.,Nascimento Ivan P.,Borra Ricardo C.,Dias Waldely O.,Tagliabue Aldo,Boraschi Diana,Leite Luciana C. C.

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Agenzia Italiana del Farmaco, Ministero della Salute

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference42 articles.

1. The BCG experience: implications for future vaccines against tubérculosis;Bloom,1994

2. 7396BCG Vaccines: WHO Position Paper - February 2018932018

3. Tuberculosis vaccines: a strategic blueprint for the next decade;Brennan;Tuberculosis.,2012

4. History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story;Herr;J Urol.,2008

5. Non-muscle invasive bladder cancer: a primer on immunotherapy;Maruf;Cancer Biol Med.,2016

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence Study Reveals Pertussis Underreporting in Brazil and Calls for Adolescent/Young Adult Boosting: Mouse Model Demonstrates Immunity Restoration;2024

2. Mycobacterial DNA-binding protein 1 is critical for BCG survival in stressful environments and simultaneously regulates gene expression;Scientific Reports;2023-08-29

3. Unlocking The Human Urobiome: Impact On Health and Disease- A Review;International Journal of Life Science and Pharma Research;2022-11-26

4. FGFBP1 as a potential biomarker predicting bacillus Calmette–Guérin response in bladder cancer;Frontiers in Immunology;2022-09-02

5. Recombinant BCG to Enhance Its Immunomodulatory Activities;Vaccines;2022-05-23